(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Breaking News: WISeKey-FOSSA WISeSat-Ready Satellite Launch, Stereotaxis-Abbott Collaboration and Dell's Price Target Boost Shake Up Tech Market

  • May 19th, 2023
  • 522 views

WISeKey International Holding Ltd (Nasdaq: WKEY) made an exciting announcement today, revealing a new collaboration with FOSSA Systems to launch a series of WISeSat-Ready FOSSA powered satellites in partnership with SpaceX. 

This joint effort aims to revolutionize the satellite industry by introducing WISeSaT Satellites, which are nanosatellites designed specifically for security-IoT applications. With this technological breakthrough, WISeSat and FOSSA are set to significantly reduce satellite costs for IoT applications while simultaneously enhancing data transmission speed. The deployment of 80 satellites projected for 2024 will ensure lower latency times, enabling near real-time data transfer.

Following this groundbreaking news, $WKEY has soared, currently trading at $3.15, which represents a remarkable increase of $0.85 (+36.96%) from the previous trading session.

In another major development, Stereotaxis, Inc. (NYSE: STXS) has announced a global collaboration with Abbott Laboratories (NYSE: ABT). This collaboration aims to integrate Abbott's EnSite X EP System with Stereotaxis' Robotic Magnetic Navigation system.

By combining Abbott's cutting-edge cardiac mapping system with Stereotaxis' advanced robotic technology, this partnership will provide healthcare professionals with highly detailed real-time diagnostic information and enable them to deliver therapy with unprecedented precision and stability.

The market has responded positively to this collaboration, driving up the stock price of Stereotaxis. Currently, $STXS is trading at $2.35, reflecting an impressive increase of $0.66 (+39.36%).

Dell Technologies Inc. (NYSE: DELL) has received a positive price target revision from Evercore ISI Group, increasing it from $50 to $55.

In the current trading session, $DELL is being traded at $47.74, representing a gain of $0.63 (+1.33%) 

 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)

Social Shares

Post Your Comments


Warning: Undefined array key "hashid" in /var/www/html/subs/visit_counter.php on line 13